ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FAB Fusion Antibodies Plc

3.20
-0.15 (-4.48%)
21 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.15 -4.48% 3.20 3.10 3.30 3.35 3.20 3.35 630,214 10:17:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0272 -1.18 3.05M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.35p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 9.75p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £3.05 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -1.18.

Fusion Antibodies Share Discussion Threads

Showing 3976 to 3997 of 4125 messages
Chat Pages: 165  164  163  162  161  160  159  158  157  156  155  154  Older
DateSubjectAuthorDiscuss
06/2/2024
16:06
Had a look and a company has shafted it's shareholders with an 84% discounted placing isn't one I wish to invest in . Wiped out most holders in one foul swoop . Since then it's been slow and painful with more cash raises and decreasing revenues . Not much to get excited about here at all . Low mkt cap is about it really but seeing how it's been run I'm not surprised .
bones698
06/2/2024
12:48
I think something not taken from this RNS but possible is the impact of the statement about the existing contract bringing in revenues higher than the previously agreed amount.

Allenby Capital briefing note last year said they had only earned $300k from this contract in 2022/23 as it had been moving slower than anticipated.

RNS suggests they’ve now received more than the full contract amount of $1.83m for the existing contract.

This should be a good boost for 23/24 and if already included as part of their forecast expected revenue then one assumes they're still on target and both CEO and CFO said if they hit their H2 targets they won't need to raise cash.

If it's greater amount than forecast then potentially a good boost on the runway.

On the longer term they’re also entitled to royalty and milestones from this contract which bodes well for the future.

gtc1508
06/2/2024
12:25
IMO the market is still assuming that the company will need more cash soon. The announcement today is positive of course, but it's relatively modest in size and they've said it won't make a big difference in 2024, the fees must be payable on completion? So I suppose the company will need more contracts delivering shorter-term revenue, to add to the tax credit received. Of course they may already be getting smaller contracts which are not of RNS-able size...
cyberbub
06/2/2024
09:23
It’s crazy that FAB is so lowly valued , the market has not nearly caught up with the improvement in prospects this company has
cbeadle
06/2/2024
07:48
Yesterday I noticed a good few trades taking a loss of over one grand on each. I bet them day traders are now kicking themselves. They already want 6p and I bet that will be gone in a flash.
luckyabbeygale
06/2/2024
07:18
New contract underpinning the core of the business well into 2025 there we goConfirmation no placing will occur what a time to buy and hold
bigjock36
05/2/2024
16:26
Corruption at its finest 35 percent rise to near flat
bigjock36
05/2/2024
10:19
6p is way too early to unload. This time round will see far higher than the last recent high.
luckyabbeygale
05/2/2024
10:02
Here we go again!
walter walcarpets
05/2/2024
08:49
The last rns deserved a rise of over 100 percent since no placing will ever be needed.
luckyabbeygale
05/2/2024
08:45
Lots of HE1 profit will end up here.
luckyabbeygale
01/2/2024
09:00
Fusion only slid back from 7.5p because of placing worries.
Now this has been addressed from the HMRC tax credit.
Every fall back from a rise is always replaced by a stronger rise the next time out.

luckyabbeygale
01/2/2024
07:38
Excellent news good cash runway again to get the projects over the line
bigjock36
01/2/2024
07:05
280k R&D credit in - should boost the cash position for a while
gtc1508
31/1/2024
22:30
Absolutely 💯, it’s been quiet since the NCI announcement. If only they could list on NASDAQ they would return 10-20 fold in the blink of an eye!
cbeadle
31/1/2024
20:44
Anything to evidence cash flow being sorted and this is 10 p plus in a heartbeat
bigjock36
31/1/2024
16:44
On the way back up again. I wonder if some agreements are on the way?
cbeadle
29/1/2024
15:32
https://www.londonstockexchange.com/news-article/APH/full-year-trading-update/16307097
blackhorse23
27/1/2024
09:33
Sell, sell, sell.Lemmings and mushrooms only.
ken chung
24/1/2024
09:46
Out now , and going to buy APH ( profit making health care company)
blackhorse23
24/1/2024
09:05
Disagree entirely keep trying to scare people
bigjock36
23/1/2024
18:12
Very touch and go though . Do you really want to be running on fumes and then miss break even could spell disaster. Remember you need a years cash just to keep going as a going concern at results .
A fund raise looks almost a certainty here and until clarity in revenues etc become clearer it looks best to wait on the sidelines

bones698
Chat Pages: 165  164  163  162  161  160  159  158  157  156  155  154  Older

Your Recent History

Delayed Upgrade Clock